A seismic shift is underway regarding hormone therapies for menopause. The Food and Drug Administration is considering removing long-standing “black box” warnings, a move that could dramatically alter treatment options for millions of women experiencing debilitating symptoms.
GOVERNMENT MELTDOWN AVERTED? Johnson's Last-Ditch Vote Could SAVE Us All!
